Drug Development

Articles

The European Investment Bank has provided €15 million to fund coronavirus research at IRBM.

EIB Provides €15 million to IRBM

Meg Rivers is the former senior editor for 

Podcasts

In this episode of the Drug Solutions Podcast, Meg Rivers, senior editor, interviews Joy Aho, senior product manager at Be The Match BioTherapies, about sourcing autologous and allogeneic cell therapies.

Drug Solutions Podcast: Sourcing Autologous and Allogeneic Cell Therapies

ReiThera and Exothera are collaborating to develop a large-scale, low-cost-per-dose manufacturing process to deliver novel vaccines to low and middle-income countries.

ReiThera and Exothera Collaborate on Manufacturing Vaccines for Low and Middle-income Countries

Swissmedic grants conditional marketing authorization for Novavax COVID-19 vaccine for individuals aged 18 years or older in Switzerland. 

Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

Dupixent has been approved by the EC for children aged 6 to 11 years with severe asthma with type 2 inflammation.

EC Approves Dupixent for Treatment of Severe Asthma in Young Children

FDA has granted Priority Review to Roche’s Actemra/RoActemra for the treatment of COVID-19 in hospitalized adults.

FDA Grants Priority Review to Intravenous Treatment of COVID-19 in Hospitalized Adults

ECDC and EMA have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines in the general population.

ECDC and EMA Issue Advice on Fourth Doses of mRNA COVID-19 Vaccines

NIH has announced four new grant awards to fund new tuberculosis research advancement centers. 

NIH Funds New Tuberculosis Research Advancement Centers

FDA has granted an expanded Emergency Use Authorization to Pfizer and BioNTech’s COVID-19 vaccine boosters in individuals aged 50 years and older.

Pfizer and BioNTech Receive Expanded US Emergency Use Authorization for an Additional COVID-19 Vaccine Booster 

Lonza has joined IPAC-RS, providing benefits to Lonza’s inhalation- related businesses due to IPAC-RS’ global voice of the orally inhaled and nasal drug products industry.

Formulation and Drug Delivery